• Nachrichtendetail
• 

31.05.2024 07:04:41 - dpa-AFX: *REGENERON: FDA EXTENDS TARGET ACTION DATE OF SBLA FOR DUPIXENT FOR COPD PATIENTS WITH TYPE 2 INFLAMMATION BY THREE MONTHS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	REGENERON PHARMAC.DL-,001	881535	Frankfurt	1.085,500	20.08.24 08:11:24	+20,000	+1,88%	1.081,500	1.087,500	1.085,500	1.065,500